Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) In 2025: Will It Be Worth Investing In?
In the last trading session, 2.59 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was -0.00. Most recently the company’s
In the last trading session, 2.59 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was -0.00. Most recently the company’s
In last trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.47 million shares changing hands with its beta currently measuring 0.10. Company’s recent per share price
During the last session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares were 1.73 million, with the beta value of the company hitting 0.25. At the end
In the last trading session, 2.29 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was 0.25. Most recently the company’s
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares stood at 4.0 million during the last session, with the company’s beta value hitting 0.21. At the close of
In the last trading session, 7.33 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.28. With the company’s per share
In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.49 million shares changing hands at last check today with its beta currently measuring 0.25. Company’s
© 2024, Powered by Smart TechOne